241 related articles for article (PubMed ID: 33893149)
1. NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation.
Papachristodoulou A; Rodriguez-Calero A; Panja S; Margolskee E; Virk RK; Milner TA; Martina LP; Kim JY; Di Bernardo M; Williams AB; Maliza EA; Caputo JM; Haas C; Wang V; De Castro GJ; Wenske S; Hibshoosh H; McKiernan JM; Shen MM; Rubin MA; Mitrofanova A; Dutta A; Abate-Shen C
Cancer Discov; 2021 Sep; 11(9):2316-2333. PubMed ID: 33893149
[TBL] [Abstract][Full Text] [Related]
2. Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression.
Papachristodoulou A; Heidegger I; Virk RK; Di Bernardo M; Kim JY; Laplaca C; Picech F; Schäfer G; De Castro GJ; Hibshoosh H; Loda M; Klocker H; Rubin MA; Zheng T; Benson MC; McKiernan JM; Dutta A; Abate-Shen C
Eur Urol; 2024 Apr; 85(4):361-372. PubMed ID: 37659962
[TBL] [Abstract][Full Text] [Related]
3. Spatiofunctional Dynamics of NKX3.1 to Safeguard the Prostate from Cancer.
Finch AJ; Baena E
Cancer Discov; 2021 Sep; 11(9):2132-2134. PubMed ID: 34479975
[TBL] [Abstract][Full Text] [Related]
4. Cooperation of loss of
Le Magnen C; Virk RK; Dutta A; Kim JY; Panja S; Lopez-Bujanda ZA; Califano A; Drake CG; Mitrofanova A; Abate-Shen C
Dis Model Mech; 2018 Nov; 11(11):. PubMed ID: 30266798
[TBL] [Abstract][Full Text] [Related]
5. Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis.
Ouyang X; DeWeese TL; Nelson WG; Abate-Shen C
Cancer Res; 2005 Aug; 65(15):6773-9. PubMed ID: 16061659
[TBL] [Abstract][Full Text] [Related]
6. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis.
Song H; Zhang B; Watson MA; Humphrey PA; Lim H; Milbrandt J
Oncogene; 2009 Sep; 28(37):3307-19. PubMed ID: 19597465
[TBL] [Abstract][Full Text] [Related]
7. Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition.
Dutta A; Panja S; Virk RK; Kim JY; Zott R; Cremers S; Golombos DM; Liu D; Mosquera JM; Mostaghel EA; Barbieri CE; Mitrofanova A; Abate-Shen C
Eur Urol; 2017 Oct; 72(4):499-506. PubMed ID: 28385453
[TBL] [Abstract][Full Text] [Related]
8. Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer.
Asatiani E; Huang WX; Wang A; Rodriguez Ortner E; Cavalli LR; Haddad BR; Gelmann EP
Cancer Res; 2005 Feb; 65(4):1164-73. PubMed ID: 15734999
[TBL] [Abstract][Full Text] [Related]
9. [A multi-omics study on NKX3.1-related node genes in prostate cancer].
Mo LJ; Su SQ; Gu YM; Hy YL
Zhonghua Nan Ke Xue; 2016 Apr; 22(4):294-9. PubMed ID: 30088395
[TBL] [Abstract][Full Text] [Related]
10. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression.
Bowen C; Bubendorf L; Voeller HJ; Slack R; Willi N; Sauter G; Gasser TC; Koivisto P; Lack EE; Kononen J; Kallioniemi OP; Gelmann EP
Cancer Res; 2000 Nov; 60(21):6111-5. PubMed ID: 11085535
[TBL] [Abstract][Full Text] [Related]
11. Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer.
Xu LL; Srikantan V; Sesterhenn IA; Augustus M; Dean R; Moul JW; Carter KC; Srivastava S
J Urol; 2000 Mar; 163(3):972-9. PubMed ID: 10688034
[TBL] [Abstract][Full Text] [Related]
12. Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival.
Tan PY; Chang CW; Chng KR; Wansa KD; Sung WK; Cheung E
Mol Cell Biol; 2012 Jan; 32(2):399-414. PubMed ID: 22083957
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory effects of NKX3.1 on IGF-1R expression and its signalling pathway in human prostatic carcinoma PC3 cells.
Zhang PJ; Hu XY; Liu CY; Chen ZB; Ni NN; Yu Y; Yang LN; Huang ZQ; Liu QW; Jiang AL
Asian J Androl; 2012 May; 14(3):493-8. PubMed ID: 22179513
[TBL] [Abstract][Full Text] [Related]
14. Loss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progression.
Bowen C; Ostrowski MC; Leone G; Gelmann EP
Cancer Res; 2019 Aug; 79(16):4124-4134. PubMed ID: 31213464
[No Abstract] [Full Text] [Related]
15. Effects of 9-cis retinoic acid on human homeobox gene NKX3.1 expression in prostate cancer cell line LNCaP.
Jiang AL; Zhang PJ; Chen WW; Liu WW; Yu CX; Hu XY; Zhang XQ; Zhang JY
Asian J Androl; 2006 Jul; 8(4):435-41. PubMed ID: 16763719
[TBL] [Abstract][Full Text] [Related]
16. Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer.
Thangapazham R; Saenz F; Katta S; Mohamed AA; Tan SH; Petrovics G; Srivastava S; Dobi A
BMC Cancer; 2014 Jan; 14():16. PubMed ID: 24418414
[TBL] [Abstract][Full Text] [Related]
17. RAMP1 is a direct NKX3.1 target gene up-regulated in prostate cancer that promotes tumorigenesis.
Logan M; Anderson PD; Saab ST; Hameed O; Abdulkadir SA
Am J Pathol; 2013 Sep; 183(3):951-63. PubMed ID: 23867798
[TBL] [Abstract][Full Text] [Related]
18. Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis.
Kim MJ; Bhatia-Gaur R; Banach-Petrosky WA; Desai N; Wang Y; Hayward SW; Cunha GR; Cardiff RD; Shen MM; Abate-Shen C
Cancer Res; 2002 Jun; 62(11):2999-3004. PubMed ID: 12036903
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal deregulation of NKX3.1 and AURKA axis in castration-resistant prostate cancer and NEPC models.
Sooreshjani MA; Kamra M; Zoubeidi A; Shah K
J Biomed Sci; 2021 Oct; 28(1):68. PubMed ID: 34625072
[TBL] [Abstract][Full Text] [Related]
20. Haploinsufficient prostate tumor suppression by Nkx3.1: a role for chromatin accessibility in dosage-sensitive gene regulation.
Mogal AP; van der Meer R; Crooke PS; Abdulkadir SA
J Biol Chem; 2007 Aug; 282(35):25790-800. PubMed ID: 17602165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
